- Home
- HURC vs CNTX Comparison
HURC vs CNTX Comparison
Compare HURC & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURC
- CNTX
- Stock Information
- Founded
- HURC 1968
- CNTX 2015
- Country
- HURC United States
- CNTX United States
- Employees
- HURC N/A
- CNTX N/A
- Industry
- HURC Industrial Machinery/Components
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- HURC Industrials
- CNTX Health Care
- Exchange
- HURC Nasdaq
- CNTX Nasdaq
- Market Cap
- HURC 139.9M
- CNTX 149.6M
- IPO Year
- HURC N/A
- CNTX 2021
- Fundamental
- Price
- HURC $21.45
- CNTX $1.84
- Analyst Decision
- HURC
- CNTX Strong Buy
- Analyst Count
- HURC 0
- CNTX 3
- Target Price
- HURC N/A
- CNTX $6.83
- AVG Volume (30 Days)
- HURC 13.9K
- CNTX 318.3K
- Earning Date
- HURC 01-03-2025
- CNTX 11-06-2024
- Dividend Yield
- HURC 2.98%
- CNTX N/A
- EPS Growth
- HURC N/A
- CNTX N/A
- EPS
- HURC N/A
- CNTX N/A
- Revenue
- HURC $198,987,000.00
- CNTX N/A
- Revenue This Year
- HURC N/A
- CNTX N/A
- Revenue Next Year
- HURC N/A
- CNTX N/A
- P/E Ratio
- HURC N/A
- CNTX N/A
- Revenue Growth
- HURC N/A
- CNTX N/A
- 52 Week Low
- HURC $14.83
- CNTX $0.77
- 52 Week High
- HURC $28.20
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- HURC 54.21
- CNTX 37.02
- Support Level
- HURC $21.30
- CNTX $1.90
- Resistance Level
- HURC $22.00
- CNTX $2.32
- Average True Range (ATR)
- HURC 0.62
- CNTX 0.14
- MACD
- HURC -0.02
- CNTX -0.04
- Stochastic Oscillator
- HURC 51.64
- CNTX 9.80
About HURC Hurco Companies Inc.
Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metal working industry through sales, service and distribution network. The company concentrated on designing user-friendly computer control systems that can be operated by both skilled and unskilled machine tool operators. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.